Wes Kassouf
@WesKassouf
Followers
1K
Following
3K
Media
58
Statuses
1K
Professor, Urologic Oncology, McGill University Health Center. President, @CanUrolAssoc
Montreal, Canada
Joined June 2015
Very proud to share our seminal work @NatureComms on the role of #neutrophil extracellular traps in radioresistance for invasive #bladdercancer #organpreservation
3
11
63
RT @neerajaiims: Breaking News from ph3 Embark trialšEnzalutamide+ADT improve overall survival (OS) vs. ADT alone in Non-Metastatic HSPC #Pā¦.
0
63
0
RT @urotoday: Cretostimogene expanded access program provides alternative for BCG-unresponsive #BladderCancer patients. @WesKassouf @mcgillā¦.
0
3
0
Truely humbled and honoured to serve as President of our amazing #CUA association ! I look forward to the year ahead, where we continue to grow, share knowledge, collaborate, and strengthen our bonds as a community @CanUrolAssoc @mcgillu.
As CUA came to an end last night, we celebrated with a beautiful ceremony honoring exceptional members of the urological community in Canada. CONGRATULATIONS š to Dr. Wassim Kassouf, CUA 2025-2026 President! We look forward to seeing you all in 1 year in Saskatoon! @WesKassouf
17
3
77
0
5
13
RT @DrChoueiri: Congrats to the ā¦@theNCIā© Team on this landmark paper in HLRCC! It sets the SOC in this rare kidney cancer variant. ā¦@NEJā¦.
nejm.org
Hereditary leiomyomatosis and renal-cell cancer (HLRCC) is an inherited disorder characterized by germline pathogenic variants in the gene encoding fumarate hydratase and an increased risk of papil...
0
34
0
RT @RobertoContieri: A š§µ on our recent study on surveillance for IR-NMIBC @EurUrolOncol There is limited evidence oā¦.
0
14
0
RT @UroDocAsh: FDA approves UGN-102, mitomycin intravesical solution (ZUSDURIā¢ ) for Recurrent Low-Grade IR NMIBC . .
businesswire.com
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty can...
0
14
0
Thank you for the kind invitationā¦.I had a terrific experience visiting your wonderful department!.
Many thanks to @WesKassouf our visiting professor for this yearās The Ruth and Carmine T. Perrapato Visiting Professorship in Urologic Oncology @UVMUrology @UVMMedCenter .We had a great time learning about the latest innovations and challenges in the management of bladder
0
0
20
RT @UroDocAsh: Our recent publication in @EurUrolOncol demonstrates - for the first time -that an AI-powered histologic biomarker (CHAI) caā¦.
0
35
0
RT @CanUrolAssoc: #CUAGuidelines you will not want to miss this one!.Join us - registration is free>>>@WesKassouf @ā¦.
0
1
0
RT @UroDocAsh: Bladder preservation in muscle-invasive bladder cancer (MIBC) is evidence-based, patient-centered, and underutilized . The lā¦.
0
100
0
Excellent thoughtful and dynamic talks with insightful session of case discussions led by #McGill Urologic Oncology Visiting Professor @SBoorjian @mcgillu @SiTanguay
1
3
31
RT @UroDocAsh: Join us for the AUA-IBCG Bladder Cancer Forum April 28, 2ā5 pm šļø. #AUA25 @AmerUrological @IBCG_BladderCA @KKBree . @PGrivasā¦.
0
20
0
RT @CanUrolAssoc: JOIN US for Current Insights and multi-D strategies. Registration is free: #bladder @BladderCanceā¦.
0
1
0
RT @FDAOncology: FDA expands the indication for a treatment for metastatic castration-resistant prostate cancer.httā¦.
0
18
0
@DrAndreaKoko @GSK_UofT @fadbrimo @UroOncMD Armen Aprikian, Luke Lavallee, Fred Saad, Robert Sabbagh, Claudio Jeldres, Jason Izard, Victor McPherson, Nick Power.
1
1
4
Thank you to all the faculty and dynamic resident participation for a successful 2-days discussing cancer care in #urology at the 26th Canadian Senior Resident Uro-oncology Course. @CanUrolAssoc @mcgillu @uretericbud
3
2
36